United States · FDA National Drug Code directory
Olmesartan Medoxomil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-446_a1d66aa9-d0fa-4d21-bba0-ff8078c2e5af
- Product NDC
- 67877-446
- Form
- TABLET, COATED
- Composition / generic term
- Olmesartan Medoxomil
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170424
- Source listing expiry
- 20261231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, COATED in 1 BOTTLE (67877-446-05) · 67877-446-05
- 1000 TABLET, COATED in 1 BOTTLE (67877-446-10) · 67877-446-10
- 30 TABLET, COATED in 1 BOTTLE (67877-446-30) · 67877-446-30
- 1 BLISTER PACK in 1 CARTON (67877-446-33) / 10 TABLET, COATED in 1 BLISTER PACK · 67877-446-33
- 10 BLISTER PACK in 1 CARTON (67877-446-38) / 10 TABLET, COATED in 1 BLISTER PACK · 67877-446-38
- 5 BLISTER PACK in 1 CARTON (67877-446-74) / 10 TABLET, COATED in 1 BLISTER PACK · 67877-446-74
- 3 BLISTER PACK in 1 CARTON (67877-446-84) / 10 TABLET, COATED in 1 BLISTER PACK · 67877-446-84
- 90 TABLET, COATED in 1 BOTTLE (67877-446-90) · 67877-446-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →